Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome
Rachele Berria, Amalia Gastaldelli, Scott Lucidi, Renata Belfort, Eleanna De Filippis, Caraan Easton, Robert Brytzki, Kenneth Cusi, Lois Jovanovic, Ralph DeFronzo
Dive into the research topics of 'Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome'. Together they form a unique fingerprint.